| Autor: |
Ness, Roberta B., Trautmann, Gail, Richter, Holly E., Randall, Hugh, Peipert, Jeffrey F., Nelson, Deborah B., Schubeck, Diane, McNeeley, S Gene, Trout, Wayne, Bass, Debra C., Soper, David E. |
| Zdroj: |
Obstetrical and Gynecological Survey; January 2006, Vol. 61 Issue: 1 p23-25, 3p |
| Abstrakt: |
This article presents a comparison of outpatient versus inpatient treatment for pelvic inflammatory disease (PID) according to patient characteristics, including age, race, parity, and clinical subgroups. Data for evaluation were obtained from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) study of 831 women with mild-to-moderate symptoms of PID who participated in a randomized trial comparing outpatient and inpatient treatments. Pregnancy and infertility were the primary outcome measures. The inpatient treatment regimen consisted of intravenous cefoxitin (2 g every 6 hours) and intravenous or oral doxycycline (100 mg twice a day) for at least 72 hours followed by oral doxycycline (100 mg twice a day) for a total 14-day course. Women in the outpatient treatment group received a single intramuscular injection of cefoxitin (2 g) plus a single oral dose of probenecid (1 g) followed by oral doxycycline (100 mg twice daily) for 14 days. All patients were instructed to see that their partners also received appropriate treatment. Follow up included clinic visits at 5 and 30 days after treatment followed by telephone interviews every 3 months for the first year and every 4 months thereafter through June 2004. By this point, 541 patients were still in contact and had an average follow up of 84 months. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
